<DOC>
	<DOC>NCT00855660</DOC>
	<brief_summary>Investigation of the effect of Riociguat, administered as 2.5 mg IR-tablets TID over 14 days, on bone metabolism.</brief_summary>
	<brief_title>Effect of Riociguat on Bone Metabolism</brief_title>
	<detailed_description>Clinical pharmacology</detailed_description>
	<criteria>Healthy male white subjects 18 to 45 years of age BMI between 18 and 28 kg/m2 Subjects who are able to understand and follow instructions and who are able to participate in the study for the entire period Relevant deviation from the normal range in the clinical examination; in clinical chemistry, hematology, or urinalysis Resting heart rate in the awake subject below 45 BPM or above 90 BPM Systolic blood pressure below 100 mmHg or above 145 mmHg Diastolic blood pressure above 95 mmHg Relevant pathological changes in the ECG such as a second or thirddegree AV block, prolongation of the QRS complex over 120 msec or of the QT / QTcinterval over 450 msec for males History of genetic muscle or bone disease of any kind Completely sedentary or extremely fit subjects Fractures in the preceding 12 months Psychiatric diseases History of peptic ulcers or relevant gastroesophageal reflux disease Subjects with hypersensitivity to the investigational drug riociguat or ranitidine, or to inactive constituents Regular daily consumption of more than half a liter of usual beer or the equivalent quantity of approximately 20 g of alcohol in another form, more than 1 L of xanthinecontaining beverages, recent smoking history Use of medication within the 2 weeks preceding the study which could have interfered with the investigational drug riociguat or ranitidine Subjects with a medical disorder, condition or history of such that would have impaired the subject's ability to participate or complete this study in the opinion of the investigator or the sponsor</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Bone Metabolism</keyword>
</DOC>